← Eichor
Condition: Respiratory Tract Infection Bacterial Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Respiratory Tract Infection Bacterial

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Establishing a Controlled Human Infection Model of Pertactin-deficient Bordetella Pertussis
Phase 1 · 1 location(s) · Dalhousie University · NCT06827470A Randomized Trial of Prednisolone, Itraconazole, or Their Combination in Allergic Bronchopulmonary Aspergillosis
Phase 3 · 1 location(s) · Post Graduate Institute of Medical Education and Research, C · NCT06174922Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients
Phase N/A · 1 location(s) · University of Oxford · NCT05571735Oral Itraconazole Versus Combination of Systemic Glucorticoids and Oral Itraconazole in CPA-ABPA Overlap Syndrome
NA · 2 location(s) · Post Graduate Institute of Medical Education and Research, C · NCT05444946Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Phase N/A · 1 location(s) · Institut Pasteur du Cambodge · NCT07358910Towards Novel BIOmarkers to Diagnose SEPsis on the Emergency Room
Phase N/A · 3 location(s) · Amsterdam University Medical Centers (UMC), Location Academi · NCT06178822iMagIng pulmonaRy Aspergillosis Using Gallium-68-dEferoxamine
Phase 2 · 1 location(s) · Radboud University Medical Center · NCT06244979ID93+GLA-SE Vaccine Against Tuberculosis in Older Adults Aged 55-74
Phase 1 · 4 location(s) · Quratis Inc. · NCT06714513Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis
Phase 2/Phase 3 · 6 location(s) · University of California, San Francisco · NCT06441006Real-World Effectiveness of Benralizumab in Allergic Bronchopulmonary Aspergillosis
Phase N/A · 2 location(s) · Qianfoshan Hospital · NCT07530770Remote Sputum Collection in Cystic Fibrosis
Phase N/A · 3 location(s) · University of Pennsylvania · NCT06950892Caspofungin for Pneumocystis Pneumonia in PLWHIV.
Phase N/A · 1 location(s) · Instituto Nacional de Enfermedades Respiratorias · NCT0669132118F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) in Tuberculosis Patients
Phase N/A · 1 location(s) · Children's Hospital Medical Center, Cincinnati · NCT07077213Short Infusion Versus Prolonged Infusion of Ceftolozane-tazobactam Among Patients with Ventilator Associated-pneumonia
Phase 3 · 1 location(s) · University Hospital, Toulouse · NCT03581370Pediatric Pertussis in Ambulatory Settings
Phase N/A · 1 location(s) · Association Clinique Thérapeutique Infantile du val de Marne · NCT04807712Environmental Reservoirs of Non-tuberculous Mycobacteria in Cystic Fibrosis Households: A Case-control Study of Exposure
Phase N/A · 2 location(s) · Research Center Borstel · NCT07369414Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB
Phase 2 · 11 location(s) · University College, London · NCT06114628Novel Triple-dose Tuberculosis Retreatment Regimen
Phase 3 · 1 location(s) · Institute of Tropical Medicine, Belgium · NCT04260477Diagnostic Utility of Mycobacterium Tuberculosis Cell-free DNA
Phase N/A · 1 location(s) · Chinese University of Hong Kong · NCT06439810ML-Based ABPA Recurrence Prediction and Clinical Utility
Phase N/A · 1 location(s) · Qianfoshan Hospital · NCT07714863Short Course Regimen in Low Risk Active Tuberculosis- a Multicenter, Randomized, Active-controlled, Trial
Phase 3 · 8 location(s) · Kaohsiung Veterans General Hospital. · NCT06727864Finding the Optimal Regimen for Mycobacterium Abscessus Treatment
Phase 2/Phase 3 · 50 location(s) · The University of Queensland · NCT04310930Characterization of Tuberculosis Associated Lung Fibrosis and Respiratory Impairment, and Prevention Using Doxycycline
Phase 2 · 2 location(s) · Makerere University · NCT06477185ILD-SARDs Registry and Biorepository
Phase N/A · 1 location(s) · McGill University Health Centre/Research Institute of the Mc · NCT05007340Phase I Study of Single/Multiple Ascending Doses of JKN2501 for Injection in Chinese Healthy Volunteers
Phase 1 · 1 location(s) · Joincare Pharmaceutical Group Industry Co., Ltd · NCT07207291Hospital at Home for Elderly Acute Ill Patients
NA · 3 location(s) · Defactum, Central Denmark Region · NCT05360914OM 85 to Prevent Respiratory Infections in Older At Risk Patients
Phase 4 · 1 location(s) · Campus Bio-Medico University · NCT06655272Parent Study Name: Pulmonary Rehabilitation to Reduce Post-Tuberculosis Morbidity (TB Pure)
NA · 2 location(s) · Johns Hopkins University · NCT07164742Epidemiological, Clinical and Biological Characteristics of Human Anaplasmosis Cases in Alsace
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT07312474Efficacy and Safety of Prophylactic Treatment for Pneumocystis Jirovecii Pneumonia in Patients With Autoimmune Inflammat
Phase 4 · 1 location(s) · Tongji Hospital · NCT06499233
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.